Tag: CORO
FDA Panel Says Yes to Pfizer Booster Shots for People 65+
Same independent panel of experts said no to booster shots for Americans younger than 65 years
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
Physician’s Briefing Weekly Coronavirus Roundup
FDA Advisory Panel to Hold Meeting Today on COVID-19 Booster Shots
Advisory panel will review a variety of evidence, including new data from Israel
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Individuals With COVID-19 Most Infectious Around Symptom Onset
Individuals are most infectious in the two days before and three days after symptom onset
Monoclonal Antibody Therapy May Cut COVID-19 Hospitalizations
Lower hospitalization rates seen at 14, 21, 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab
Outcome Good at One Year for Majority of PIMS-TS Patients
Patients presenting with impaired cardiac function without aneurysm on echocardiography had all recovered by day 74
Risk for Hospitalization, ED Use Up With SARS-CoV-2 Delta Variant
Risk increased for being admitted to the hospital or attending emergency care within 14 days with delta variant
42.4 Percent of U.S. Teens Have Received at Least One COVID-19 Shot
Vaccination coverages vary by state, with rates of one dose or more ranging from from 20.2 percent in Mississippi to 70.1 percent in Vermont
